To enhance competition for prescription drugs by increasing the ability of the Department of Justice and Federal Trade Commission to enforce existing antitrust laws regarding brand name drugs and generic drugs.
Sen. Chuck Grassley (R-IA)Text
Submitted
Plain text for this version is not available yet.
Legislative Activity
Stay on top of the latest movement without scrolling through every action
Senate amendment agreed to: Amendment SA 974 agreed to in Senate by Voice Vote.
June 25, 2003
View full timeline
Senate amendment agreed to: Amendment SA 974 agreed to in Senate by Voice Vote.
June 25, 2003
Considered by Senate. (consideration: CR S8480, S8538)
June 25, 2003
Amendment SA 974 agreed to in Senate by Voice Vote.
June 25, 2003
Considered by Senate. (consideration: CR S8386, S8430-8431)
June 24, 2003
Senate amendment proposed (on the floor): Amendment SA 974 proposed by Senator Grassley.(consideration: CR S8351-8352; text: CR S8351)
June 23, 2003
Amendment SA 974 proposed by Senator Grassley. (consideration: CR S8351-8352; text: CR S8351) To enhance competition for prescription drugs by increasing the ability of the Department of Justice and Federal Trade Commission to enforce existing antitrust laws regarding brand name drugs and generic drugs.
June 23, 2003
Senate amendment submitted
June 20, 2003
Amendments
1 amendmentOffered to this amendment
Amendments
1 amendmentOffered to this amendment